Peptide library › Infections
Polymyxin B and colistin
Also known as Polymyxin E, Colistimethate, Coly-Mycin M
Old peptide antibiotics now kept as a last resort for multidrug-resistant gram-negative infections.
What people use it for
- Multidrug-resistant gram-negative infections, such as Pseudomonas and Acinetobacter
- Eye and skin preparations (polymyxin B)
What Polymyxin B and colistin does in the body
Cationic lipopeptides that bind the outer membrane of gram-negative bacteria and break it open.
Strength of evidence
Moderate: decades of use, but limited modern trial data; kept for resistant infections because of toxicity.
Look up the evidence
- Reviews on PubMed: Summaries of the published research
- Clinical trials on PubMed: Published studies in people
- ClinicalTrials.gov: Registered trials, past and ongoing
- Prescribing information (DailyMed, US): Official US label
- Patient leaflets (emc, UK): Official UK product information
Live searches of official databases. New to the terms? See the glossary.
Reported side effects & risks
- Kidney damage
- Nerve effects: tingling, dizziness, muscle weakness
- Breathing problems from nerve-muscle blockade (rare)
Who should avoid it or take extra care
- Myasthenia gravis
- Existing kidney disease needs careful dosing
Not a complete list. Check with a doctor or pharmacist about your own health and medicines.
Regulatory status
FDA-approved decades ago. Injectable forms carry boxed warnings for kidney and nerve toxicity.
How it's taken
Route: Drip into a vein, inhaled, or in eye drops and ointments
How long it lasts (half-life): Several hours; longer with kidney problems
Storage
Stored and prepared by the pharmacy or clinic, following the product label.
Latest research & news
- Colistin Use in Neonates ICU Patients With Gram Negative Resistant Infection
Clinical trial · Completed · Updated · ClinicalTrials.gov · 20 Nov 2026 - Efficacy of Colistin Monotherapy Versus Colistin Plus Minocycline for Carbapenem-Resistant A. Baumannii Infection
Clinical trial · Recruiting · Phase 4 · Updated · ClinicalTrials.gov · 18 Nov 2026 - Colistin Heteroresistance in Multidrug-Resistant Gram-Negative Bacilli
Clinical trial · Not yet recruiting · Updated · ClinicalTrials.gov · 18 Nov 2026
Picked automatically from PubMed, ClinicalTrials.gov and the FDA, and updated daily. Early, lab and animal studies often don't carry over to people.
Keep track of Polymyxin B and colistin privately
Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.
Open Polymyxin B and colistin in Fiala How to installMore in Infections
- BacitracinPeptide antibiotic in over-the-counter ointments for minor cuts and grazes.
- Dalbavancin, oritavancin and telavancinLong-acting hospital antibiotics related to vancomycin, used for serious skin infections including MRSA.
- DaptomycinHospital antibiotic for serious skin and bloodstream infections, including MRSA.
- EchinocandinsFamily of hospital antifungal drugs for serious yeast and mould infections.
- VancomycinLong-established hospital antibiotic for MRSA and other serious infections; taken by mouth for C. difficile.
- EnfuvirtideFirst HIV fusion inhibitor, a twice-daily injection for resistant HIV; discontinued in the US in 2025.
- MurepavadinExperimental antibiotic designed to target Pseudomonas, the main lung infection in cystic fibrosis.
- BrilacidinExperimental drug that mimics the body's own antimicrobial defensins, studied for infections and inflammation.